Analyst Ratings January 26, 2026

KBW Lifts S&T Bancorp Price Target to $44 After Strong Q4 Performance

Buybacks and outperformance on net interest income and fees drive modest estimate revisions as credit metrics remain mixed

By Caleb Monroe STBA
KBW Lifts S&T Bancorp Price Target to $44 After Strong Q4 Performance
STBA

Keefe, Bruyette & Woods increased its price target on S&T Bancorp Inc. (STBA) to $44.00 from $42.00 while keeping its existing rating. The raise follows a stronger-than-expected finish to 2025, with pre-provision net revenue beating KBW's forecast by $0.05 per share, supported by higher net interest income and fee revenue. S&T completed a repurchase equal to 2% of outstanding shares in Q4 2025 and authorized a new $100 million buyback, roughly 6% of shares outstanding. KBW bumped 2026 and 2027 earnings estimates by 3% largely because of the smaller share count, but it flagged credit metrics and an approaching regulatory threshold as key variables for any re-rating.

Key Points

  • KBW raised its price target on S&T Bancorp to $44.00 from $42.00 while keeping the same rating, citing a stronger-than-expected finish to 2025.
  • Pre-provision net revenue beat KBW's estimate by $0.05 per share due to higher net interest income and fee revenue; Q4 2025 EPS of $0.89 and revenue of $105.29 million modestly exceeded consensus.
  • S&T repurchased 2% of outstanding shares in Q4 2025 and authorized an additional $100 million buyback (about 6% of shares), prompting KBW to raise 2026 and 2027 earnings estimates by 3% because of a smaller share base. Sectors impacted: regional banking, financials, and equity markets.

Keefe, Bruyette & Woods has increased its price target on S&T Bancorp Inc. to $44.00 from $42.00 and left its current rating unchanged. The research firm tied the upward revision to what it called a "strong finish to 2025," noting specific line-item performance that exceeded its expectations.

KBW highlighted that S&T Bancorp's pre-provision net revenue outpaced the firm's estimate by $0.05 per share. The firm attributed that beat to stronger net interest income and higher fee revenue, signaling that the bank's revenue mix in the quarter provided a modest upside versus forecasts.

Capital return activity factored into KBW's updated outlook. S&T repurchased roughly 2% of its outstanding shares in the fourth quarter of 2025. Management also announced a new $100 million share repurchase authorization, which KBW notes represents about 6% of the company's outstanding shares. The reduction in share count was a material input to the research firm's modeling.

Accordingly, KBW raised its earnings projections for 2026 and 2027 by 3% each. The firm explained that the revisions reflected primarily the lower share count resulting from the Q4 2025 repurchase and additional modest buybacks that KBW incorporated into its first-half-2026 assumptions.

At the same time, KBW identified several elements that could influence whether the stock is re-rated by the market. The firm pointed to credit-related volatility, noting mixed developments in the fourth quarter: criticized and classified assets declined, but non-performing assets increased and net charge-offs were higher. KBW also highlighted the potential effects associated with S&T crossing the $10 billion regulatory threshold, indicating that mitigating those impacts will be important for investor sentiment.

S&T Bancorp's reported results for the fourth quarter of 2025 showed modest upside versus consensus. The company posted earnings per share of $0.89, versus an expected $0.88, a 1.14% surprise. Revenue totaled $105.29 million compared with an anticipated $103.44 million, a 1.79% surprise. According to the report, analysts and investors reacted favorably to the numbers and the company's capital-return actions.

Following the earnings and repurchase announcements, S&T's stock experienced a notable move higher. The article's reporting notes that analyst firms have not issued recent upgrades or downgrades on the name, leaving KBW's price-target change as the most prominent near-term research development.


Context and implications

The combination of slightly stronger-than-expected revenue and EPS, active share repurchases and a larger buyback authorization directly reduced the company's share count, which in turn prompted modest upward adjustments to multi-year earnings estimates. However, the mixed credit metrics and the prospect of increased regulatory scrutiny tied to the $10 billion threshold remain explicit areas of uncertainty that KBW says could affect future valuation.

Investors and market participants tracking regional banking and financials will likely weigh the buyback-driven per-share improvements against the credit dynamics and potential regulatory implications when assessing S&T's near-term outlook.

Risks

  • Credit metrics remain mixed - while criticized and classified assets fell in Q4 2025, non-performing assets rose and net charge-offs were higher, creating uncertainty for credit-related earnings stability. Affected sector: banking and financials.
  • Crossing the $10 billion regulatory threshold introduces potential regulatory and compliance impacts that could affect capital planning and operational costs. Affected sector: regional banking and financial services.
  • Reliance on buybacks to lift per-share metrics leaves some sensitivity to future repurchase activity; if buybacks slow, EPS and per-share measures may be less supportive of valuation. Affected sector: equity markets and investor return expectations.

More from Analyst Ratings

Palantir Gains After Lofty 2026 Guidance; Analysts Split on Outlook Feb 2, 2026 Freedom Capital Markets Starts Coverage of Nebius Group With Buy Rating, $108 Target Feb 2, 2026 Clear Street Starts Coverage on Caribou Biosciences with Buy Rating and $13 Target Feb 2, 2026 Goldman Keeps OLN Neutral at $22 as Olin Signals Rough Q1, Cost Cuts to Cushion Results Feb 2, 2026 Aletheia Capital Starts Coverage on Teradyne With Buy Rating, $400 Target Feb 2, 2026